Literature DB >> 15039437

Disruption of Meox or Gli activity ablates skeletal myogenesis in P19 cells.

Helen Petropoulos1, Peter J Gianakopoulos, Alan G Ridgeway, Ilona S Skerjanc.   

Abstract

Gli2 and Meox1 are transcription factors that are expressed in the developing somite and play roles in the commitment of cells to the skeletal muscle lineage. To further define their roles in regulating myogenesis, the function of wild type and dominant-negative forms of Gli2 and Meox1 were examined in the context of differentiating P19 stem cells. We found that Gli2 overexpression up-regulated transcript levels of Meox1 and, conversely, Meox1 overexpression resulted in the upregulation of Gli2 transcripts. Furthermore, dominant-negative forms of either Meox1 or Gli2 disrupted the ability of P19 cells to commit to the muscle lineage and to properly express either Gli2 or Meox1, respectively. Finally, Pax3 transcripts were induced by Gli2 overexpression and lost in the presence of either mutants Meox1 or Gli2. Taken together, these results support the existence of a regulatory loop between Gli2, Meox1, and Pax3 that is essential for specification of mesodermal cells into the muscle lineage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039437     DOI: 10.1074/jbc.M312612200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Authors:  Peter J Gianakopoulos; Virja Mehta; Anastassia Voronova; Yi Cao; Zizhen Yao; Josée Coutu; Xiaonan Wang; Michelle S Waddington; Stephen J Tapscott; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.

Authors:  Rachelle W Johnson; Mai P Nguyen; Susan S Padalecki; Barry G Grubbs; Alyssa R Merkel; Babatunde O Oyajobi; Lynn M Matrisian; Gregory R Mundy; Julie A Sterling
Journal:  Cancer Res       Date:  2010-12-28       Impact factor: 12.701

3.  Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Authors:  Gabriela G Loots; Michaela Kneissel; Hansjoerg Keller; Myma Baptist; Jessie Chang; Nicole M Collette; Dmitriy Ovcharenko; Ingrid Plajzer-Frick; Edward M Rubin
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

4.  Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension.

Authors:  Yongjia Fan; Michael Hsiung; Chong Cheng; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part A       Date:  2013-11-28       Impact factor: 3.845

Review 5.  Loss of heterogeneity, quiescence, and differentiation in muscle stem cells.

Authors:  Haser Hasan Sutcu; Miria Ricchetti
Journal:  Stem Cell Investig       Date:  2018-04-12

6.  Retinoic acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population.

Authors:  Tammy Ryan; Jun Liu; Alphonse Chu; Lisheng Wang; Alexandre Blais; Ilona S Skerjanc
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

7.  Arsenic inhibits hedgehog signaling during P19 cell differentiation.

Authors:  Jui Tung Liu; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-30       Impact factor: 4.219

8.  Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.

Authors:  F Nitzki; N Cuvelier; J Dräger; A Schneider; T Braun; H Hahn
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

9.  Cross talk between hedgehog and bone morphogenetic proteins occurs during cardiomyogenesis in P19 cells.

Authors:  Peter Junior Gianakopoulos; Ilona S Skerjanc
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-07-08       Impact factor: 2.416

10.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.